Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2020-09-30 Sale |
2020-10-01 5:35 pm |
MYRIAD GENETICS INC | MYGN | Verratti Mark President Assurex Health Inc. |
725 | $13.04 | $9,454 | 110,431 (Direct) |
View |
2020-09-25 Sale |
2020-09-28 12:55 pm |
MYRIAD GENETICS INC | MYGN | Verratti Mark President Assurex Health Inc. |
8,170 | $12.44 | $101,635 | 111,156 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-14 Tax Withholding |
2025-04-15 4:12 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
1,085 | $8.08 | 382,911 (Direct) |
View |
2025-03-22 Tax Withholding |
2025-03-25 4:16 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
4,989 | $10.01 | 383,996 (Direct) |
View |
2025-03-24 Tax Withholding |
2025-03-25 4:16 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
2,701 | $9.98 | 383,996 (Direct) |
View |
2025-03-13 Option Award |
2025-03-17 4:19 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
99,227 | $0 | 391,686 (Direct) |
View |
2025-03-14 Tax Withholding |
2025-03-17 4:19 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
9,576 | $10.07 | 391,686 (Direct) |
View |
2025-02-07 Option Award |
2025-03-04 7:31 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
12,758 | $0 | 302,035 (Direct) |
View |
2024-10-09 Tax Withholding |
2024-10-10 4:36 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
8,363 | $24.37 | 289,277 (Direct) |
View |
2024-09-21 Tax Withholding |
2024-09-23 4:21 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
1,075 | $27.64 | 297,640 (Direct) |
View |
2024-04-14 Tax Withholding |
2024-04-15 4:25 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
1,076 | $19.55 | 298,715 (Direct) |
View |
2024-03-22 Tax Withholding |
2024-03-25 4:31 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
4,893 | $22.24 | 299,791 (Direct) |
View |
2024-03-14 Option Award |
2024-03-18 4:45 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
58,631 | $0 | 304,684 (Direct) |
View |
2024-03-15 Tax Withholding |
2024-03-18 4:45 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
3,686 | $21.16 | 304,684 (Direct) |
View |
2023-10-09 Tax Withholding |
2023-10-10 4:21 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
8,366 | $15.01 | 249,739 (Direct) |
View |
2023-09-26 Tax Withholding |
2023-09-27 4:30 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
3,523 | $15.99 | 258,105 (Direct) |
View |
2023-09-21 Tax Withholding |
2023-09-22 4:26 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
1,076 | $16.77 | 261,628 (Direct) |
View |
2023-04-14 Tax Withholding |
2023-04-17 6:22 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
703 | $22.27 | 262,704 (Direct) |
View |
2023-03-24 Tax Withholding |
2023-03-27 4:27 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
2,669 | $23.72 | 263,407 (Direct) |
View |
2023-03-22 Tax Withholding |
2023-03-23 4:28 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
1,351 | $22.91 | 266,076 (Direct) |
View |
2023-03-15 Option Award |
2023-03-16 4:29 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
39,405 | $0 | 267,427 (Direct) |
View |
2022-10-09 Tax Withholding |
2022-10-11 4:35 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
8,366 | $19.62 | 228,022 (Direct) |
View |
2022-09-26 Tax Withholding |
2022-09-27 4:32 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
2,293 | $18.41 | 236,388 (Direct) |
View |
2022-09-25 Tax Withholding |
2022-09-27 4:32 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
2,793 | $18.69 | 236,388 (Direct) |
View |
2022-09-21 Tax Withholding |
2022-09-22 4:38 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
702 | $20.2 | 241,474 (Direct) |
View |
2022-08-25 Tax Withholding |
2022-08-26 4:23 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
1,031 | $24.89 | 242,176 (Direct) |
View |
2022-04-14 Option Award |
2022-04-14 5:00 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark Chief Commercial Officer |
10,000 | $0 | 243,207 (Direct) |
View |
2022-03-24 Tax Withholding |
2022-03-25 5:06 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark President, Mental Health |
2,666 | $25.32 | 233,207 (Direct) |
View |
2022-03-22 Option Award |
2022-03-23 4:52 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark President, Mental Health |
19,238 | $0 | 235,873 (Direct) |
View |
2022-02-16 Option Award |
2022-02-18 5:11 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark President, Mental Health |
22,616 | $0 | 216,635 (Direct) |
View |
2021-10-09 Tax Withholding |
2021-10-12 4:55 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark President, Myriad Neuroscience |
8,340 | $30.88 | 194,019 (Direct) |
View |
2021-09-25 Tax Withholding |
2021-09-27 9:12 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark President, Myriad Neuroscience |
10,260 | $33.31 | 202,359 (Direct) |
View |
2021-09-21 Option Award |
2021-09-23 5:22 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark President, Myriad Neuroscience |
56,571 | $0 | 212,619 (Direct) |
View |
2021-08-25 Tax Withholding |
2021-08-26 9:55 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark President, Myriad Neuroscience |
1,082 | $34.81 | 156,048 (Direct) |
View |
2021-03-24 Option Award |
2021-03-26 4:23 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark President, Myriad Neuroscience |
15,441 | $0 | 157,130 (Direct) |
View |
2020-10-08 Option Award |
2020-10-13 08:11 am |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark President Assurex Health Inc. |
31,258 | $0 | 141,689 (Direct) |
View |
2020-09-24 Option Award |
2020-09-28 12:55 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark President Assurex Health Inc. |
32,800 | $0 | 111,156 (Direct) |
View |
2020-08-12 Option Award |
2020-08-17 4:29 pm |
N/A N/A |
MYRIAD GENETICS INC | MYGN | Verratti Mark President Assurex Health Inc. |
7,467 | $0 | 86,526 (Direct) |
View |